222 related articles for article (PubMed ID: 22907756)
1. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
2. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
Iqbal N; Mei J; Liu J; Skapek SX
Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
[TBL] [Abstract][Full Text] [Related]
3. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
Silva RL; Thornton JD; Martin AC; Rehg JE; Bertwistle D; Zindy F; Skapek SX
EMBO J; 2005 Aug; 24(15):2803-14. PubMed ID: 16037818
[TBL] [Abstract][Full Text] [Related]
4. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
Iqbal NS; Devitt CC; Sung CY; Skapek SX
Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
[TBL] [Abstract][Full Text] [Related]
5. The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.
Thornton JD; Silva RL; Martin AC; Skapek SX
Cell Cycle; 2005 Oct; 4(10):1316-9. PubMed ID: 16205116
[TBL] [Abstract][Full Text] [Related]
6. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
7. A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye.
Zheng Y; Devitt C; Liu J; Mei J; Skapek SX
Dev Biol; 2013 Aug; 380(1):49-57. PubMed ID: 23665474
[TBL] [Abstract][Full Text] [Related]
8. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).
Ewing SJ; Zhu S; Zhu F; House JS; Smart RC
Cell Death Differ; 2008 Nov; 15(11):1734-44. PubMed ID: 18636078
[TBL] [Abstract][Full Text] [Related]
9. P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
Zhang Y; Saporita AJ; Weber JD
Mol Cell Biol; 2013 Apr; 33(8):1594-607. PubMed ID: 23401854
[TBL] [Abstract][Full Text] [Related]
10. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
11. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
[TBL] [Abstract][Full Text] [Related]
12. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
[TBL] [Abstract][Full Text] [Related]
13. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous activation of p19Arf in pulmonary artery smooth muscle cells.
Solodushko V; Alvarez DF; Viator R; Messerall T; Fouty B
Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L642-7. PubMed ID: 21216978
[TBL] [Abstract][Full Text] [Related]
15. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
[TBL] [Abstract][Full Text] [Related]
16. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
17. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
[TBL] [Abstract][Full Text] [Related]
18. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
19. Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Gromley A; Churchman ML; Zindy F; Sherr CJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6285-90. PubMed ID: 19339492
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar p19ARF, unlike mitochondrial smARF, is incapable of inducing p53-independent autophagy.
Reef S; Kimchi A
Autophagy; 2008 Oct; 4(7):866-9. PubMed ID: 18719357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
